Page last updated: 2024-12-05

n-tetradecylamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

n-Tetradecylamine, also known as myristylamine, is a long-chain aliphatic amine with a straight carbon chain of 14 atoms. It is a colorless to pale yellow waxy solid at room temperature.
n-Tetradecylamine is a common starting material in the synthesis of various organic compounds, including surfactants, pharmaceuticals, and agricultural chemicals. It is also used as a corrosion inhibitor in metal processing.
n-Tetradecylamine has been found to exhibit antifungal and antibacterial properties, making it a potential candidate for the development of new antimicrobial agents.
n-Tetradecylamine is a versatile compound with a wide range of applications, leading to its ongoing study and research in various fields.'

N-tetradecylamine: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID16217
CHEMBL ID110011
CHEBI ID165595
SCHEMBL ID27093
MeSH IDM0074272

Synonyms (47)

Synonym
bdbm50147580
NCI60_022211
nsc-66437
2016-42-4
1-tetradecanamine
armeen 14
tetradecanamine
n-tetradecylamine
myristylamine
tetradecylamine
1-aminotetradecane
nsc66437
tetradecan-1-amine
tetradecylamine, 95%
NCGC00164335-01
monotetradecylamine
einecs 217-950-9
alamine 5d
brn 1633740
nsc 66437
ai3-15076
1-tetradecylamine
68037-91-2
CHEBI:165595
CHEMBL110011 ,
T0090
AKOS009159253
unii-nom20l9lft
nom20l9lft ,
ec 217-950-9
4-04-00-00812 (beilstein handbook reference)
einecs 268-214-9
FT-0633980
SCHEMBL27093
1-tetradecyl amine
tetradecyl amine
tetradecylamine hydrochloride (salt/mix)
myristamine
armeen 14d
W-109740
1-amino-tetradecane
DTXSID9040768
mfcd00008157
F20969
STR11666
Q27284979
SB79370

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
"The objective of this study was to investigate the in vitro activities of lauric acid and myristylamine in combination with six antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA)."( In vitro activity of lauric acid or myristylamine in combination with six antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA).
Aoyama, Y; Higuchi, S; Hirakata, Y; Ichikawa, N; Kamihira, S; Kitahara, T; Kohno, S; Nakashima, M; Sasaki, H, 2006
)
0.33
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
alkylamineAny primary amine in which the substituent attached to nitrogen is an alkyl group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency31.62280.010039.53711,122.0200AID588547
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Dynamin-1Homo sapiens (human)IC50 (µMol)20.25003.15004.17335.0000AID63727
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (11)

Processvia Protein(s)Taxonomy
endocytosisDynamin-1Homo sapiens (human)
receptor-mediated endocytosisDynamin-1Homo sapiens (human)
endosome organizationDynamin-1Homo sapiens (human)
modulation of chemical synaptic transmissionDynamin-1Homo sapiens (human)
protein homooligomerizationDynamin-1Homo sapiens (human)
protein homotetramerizationDynamin-1Homo sapiens (human)
regulation of vesicle sizeDynamin-1Homo sapiens (human)
clathrin coat assembly involved in endocytosisDynamin-1Homo sapiens (human)
vesicle scissionDynamin-1Homo sapiens (human)
receptor internalizationDynamin-1Homo sapiens (human)
synaptic vesicle budding from presynaptic endocytic zone membraneDynamin-1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (11)

Processvia Protein(s)Taxonomy
RNA bindingDynamin-1Homo sapiens (human)
GTPase activityDynamin-1Homo sapiens (human)
protein bindingDynamin-1Homo sapiens (human)
GTP bindingDynamin-1Homo sapiens (human)
phosphatidylinositol-4,5-bisphosphate bindingDynamin-1Homo sapiens (human)
phosphatidylinositol-3,4,5-trisphosphate bindingDynamin-1Homo sapiens (human)
GDP bindingDynamin-1Homo sapiens (human)
protein kinase bindingDynamin-1Homo sapiens (human)
identical protein bindingDynamin-1Homo sapiens (human)
protein homodimerization activityDynamin-1Homo sapiens (human)
microtubule bindingDynamin-1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (15)

Processvia Protein(s)Taxonomy
photoreceptor inner segmentDynamin-1Homo sapiens (human)
plasma membraneDynamin-1Homo sapiens (human)
clathrin-coated pitDynamin-1Homo sapiens (human)
endocytic vesicleDynamin-1Homo sapiens (human)
chromaffin granuleDynamin-1Homo sapiens (human)
cell projectionDynamin-1Homo sapiens (human)
extracellular exosomeDynamin-1Homo sapiens (human)
photoreceptor ribbon synapseDynamin-1Homo sapiens (human)
presynapseDynamin-1Homo sapiens (human)
presynaptic endocytic zone membraneDynamin-1Homo sapiens (human)
glutamatergic synapseDynamin-1Homo sapiens (human)
membrane coatDynamin-1Homo sapiens (human)
plasma membraneDynamin-1Homo sapiens (human)
synapseDynamin-1Homo sapiens (human)
microtubuleDynamin-1Homo sapiens (human)
cytoplasmDynamin-1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (20)

Assay IDTitleYearJournalArticle
AID1126709Cytotoxicity against human BT549 cells assessed as reduction cell viability after 48 hrs by MTS assay2014European journal of medicinal chemistry, May-06, Volume: 78Cytotoxic properties of D-gluco-, D-galacto- and D-manno-configured 2-amino-2-deoxy-glycerolipids against epithelial cancer cell lines and BT-474 breast cancer stem cells.
AID1489290Cytotoxicity against human JIMT1 cells assessed as decrease in cell viability after 48 hrs by MTS assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Amphiphilic Modulation of Glycosylated Antitumor Ether Lipids Results in a Potent Triamino Scaffold against Epithelial Cancer Cell Lines and BT474 Cancer Stem Cells.
AID1489294Cytotoxicity against human DU145 cells assessed as decrease in cell viability after 48 hrs by MTS assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Amphiphilic Modulation of Glycosylated Antitumor Ether Lipids Results in a Potent Triamino Scaffold against Epithelial Cancer Cell Lines and BT474 Cancer Stem Cells.
AID1126707Cytotoxicity against human BT474 cells assessed as reduction cell viability after 48 hrs by MTS assay2014European journal of medicinal chemistry, May-06, Volume: 78Cytotoxic properties of D-gluco-, D-galacto- and D-manno-configured 2-amino-2-deoxy-glycerolipids against epithelial cancer cell lines and BT-474 breast cancer stem cells.
AID1489325Induction of disintegration of human BT474 cancer stem cell spheroids at 20 uM after 3 days by microscopic method2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Amphiphilic Modulation of Glycosylated Antitumor Ether Lipids Results in a Potent Triamino Scaffold against Epithelial Cancer Cell Lines and BT474 Cancer Stem Cells.
AID1126712Cytotoxicity against human PC3 cells assessed as reduction cell viability after 48 hrs by MTS assay2014European journal of medicinal chemistry, May-06, Volume: 78Cytotoxic properties of D-gluco-, D-galacto- and D-manno-configured 2-amino-2-deoxy-glycerolipids against epithelial cancer cell lines and BT-474 breast cancer stem cells.
AID1489295Cytotoxicity against human PC3 cells assessed as decrease in cell viability after 48 hrs by MTS assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Amphiphilic Modulation of Glycosylated Antitumor Ether Lipids Results in a Potent Triamino Scaffold against Epithelial Cancer Cell Lines and BT474 Cancer Stem Cells.
AID664448Inhibition of Wistar/ST rat lung NAAA assessed as conversion of [14C]PEA to [14C]palmitic acid at 100 uM after 20 mins2012Bioorganic & medicinal chemistry, Jun-01, Volume: 20, Issue:11
Lipophilic amines as potent inhibitors of N-acylethanolamine-hydrolyzing acid amidase.
AID1126711Cytotoxicity against human DU145 cells assessed as reduction cell viability after 48 hrs by MTS assay2014European journal of medicinal chemistry, May-06, Volume: 78Cytotoxic properties of D-gluco-, D-galacto- and D-manno-configured 2-amino-2-deoxy-glycerolipids against epithelial cancer cell lines and BT-474 breast cancer stem cells.
AID63727Concentration required against dynamin-1 GTPase activity of sheep brain.2004Bioorganic & medicinal chemistry letters, Jun-21, Volume: 14, Issue:12
Long chain amines and long chain ammonium salts as novel inhibitors of dynamin GTPase activity.
AID1069924Antiviral activity against HCV infected in human Huh7 cells assessed as reduction in RNA level by luciferase reporter gene assay relative to control2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Dual inhibition of HCV and HIV by ring-expanded nucleosides containing the 5:7-fused imidazo[4,5-e][1,3]diazepine ring system. In vitro results and implications.
AID1489291Cytotoxicity against human MDA-MB-231 cells assessed as decrease in cell viability after 48 hrs by MTS assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Amphiphilic Modulation of Glycosylated Antitumor Ether Lipids Results in a Potent Triamino Scaffold against Epithelial Cancer Cell Lines and BT474 Cancer Stem Cells.
AID1069917Antiviral activity against HIV2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Dual inhibition of HCV and HIV by ring-expanded nucleosides containing the 5:7-fused imidazo[4,5-e][1,3]diazepine ring system. In vitro results and implications.
AID1126710Cytotoxicity against human MIAPaCa2 cells assessed as reduction cell viability after 48 hrs by MTS assay2014European journal of medicinal chemistry, May-06, Volume: 78Cytotoxic properties of D-gluco-, D-galacto- and D-manno-configured 2-amino-2-deoxy-glycerolipids against epithelial cancer cell lines and BT-474 breast cancer stem cells.
AID1273073Antitubercular activity against Mycobacterium tuberculosis BCG after 7 days by alamar blue assay2016Bioorganic & medicinal chemistry, Feb-15, Volume: 24, Issue:4
Synthesis and anti-tuberculosis activity of glycitylamines.
AID1489293Cytotoxicity against human MIAPaCa2 cells assessed as decrease in cell viability after 48 hrs by MTS assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Amphiphilic Modulation of Glycosylated Antitumor Ether Lipids Results in a Potent Triamino Scaffold against Epithelial Cancer Cell Lines and BT474 Cancer Stem Cells.
AID1489292Cytotoxicity against human BT474 cells assessed as decrease in cell viability after 48 hrs by MTS assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Amphiphilic Modulation of Glycosylated Antitumor Ether Lipids Results in a Potent Triamino Scaffold against Epithelial Cancer Cell Lines and BT474 Cancer Stem Cells.
AID1126708Cytotoxicity against human JIMT1 cells assessed as reduction cell viability after 48 hrs by MTS assay2014European journal of medicinal chemistry, May-06, Volume: 78Cytotoxic properties of D-gluco-, D-galacto- and D-manno-configured 2-amino-2-deoxy-glycerolipids against epithelial cancer cell lines and BT-474 breast cancer stem cells.
AID1489324Induction of disintegration of human BT474 cancer stem cell spheroids at 7.5 uM after 3 days by microscopic method2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Amphiphilic Modulation of Glycosylated Antitumor Ether Lipids Results in a Potent Triamino Scaffold against Epithelial Cancer Cell Lines and BT474 Cancer Stem Cells.
AID1489321Cytotoxicity against human BT474 cancer stem cell spheroids assessed as decrease in cell viability up to 20 uM after 48 hrs by MTS assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Amphiphilic Modulation of Glycosylated Antitumor Ether Lipids Results in a Potent Triamino Scaffold against Epithelial Cancer Cell Lines and BT474 Cancer Stem Cells.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (11.76)18.7374
1990's4 (23.53)18.2507
2000's5 (29.41)29.6817
2010's6 (35.29)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.80

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.80 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index4.74 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.80)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other18 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]